{"id":32896,"date":"2020-08-10T11:39:19","date_gmt":"2020-08-10T10:39:19","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=32896"},"modified":"2023-04-29T23:09:40","modified_gmt":"2023-04-29T22:09:40","slug":"nikolaos-venizelos","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/","title":{"rendered":"Nikolaos Venizelos"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n\n\t<h2>Prof. Nikolaos Venizelos<\/h2>\n<h4>Professor emeritus and Head of the Neuropsychiatric Research Laboratory &amp; Biobank, Nutrition-Gut-Brain Interactions Research Centre (NGBI), School of Medical Sciences at \u00d6rebro University<\/h4>\n\t<p>Nikolaos Venizelos studied biomedicine at Uppsala University in Sweden and in 1981 after his Master thesis in clinical chemistry &amp; physiology at the Karolinska Institutet, he obtained a professional certification\/license as a specialist in Clinical Chemistry from the Ministry of Health in Greece.<\/p>\n<p>In 1982 he was appointed as a research associate at the Dept. of clinical chemistry, Karolinska Hospital, and during 1986-1999 he was head of the Cell Culture &amp; Biobank Section at the Centre for Inherited Metabolic Diseases (CMMS), Karolinska University Hospital. Post and prenatal cellular laboratory diagnosis of Inherited Metabolic Disorders, deficiency of rare enzymes was the main focus.<\/p>\n<p>1997 he obtained a PhD in Medicine at Karolinska Institute and was further appointed as Senior Researcher and in 1999 he received a position in the Section of Psychiatry at Karolinska University Hospital.<\/p>\n<p>In 2001, in connection to his position as Assistant Professor (University Lecturer), he moved to the Department of Clinical Medicine, School of Health and Medical Sciences at \u00d6rebro University, where he established the Neuropsychiatric Research Laboratory. The research was\/is focused on the mechanism of transport of the amino acids tyrosine and tryptophan, precursors of dopamine and serotonin in schizophrenia and related disorders as bipolar, autism and ADHD.\u00a0The research conducted in Neuropsychiatric Research Laboratory is leading both nationally and internationally.<\/p>\n<p>2004 he obtained a Docentship (Associate professor) and was further appointed as Programme Director of Biomedicine Education Programme (4 years program) at the \u00d6rebro University.<\/p>\n<p>In 2012 he was appointed as a full Professor in Biomedical Sciences, at Faculty of Medicine and Health, \u00d6rebro University. Prof. Venizelos&#8217;s conduct research in Experimental Neuropsychiatry with actual focus to explore the role and regulatory mechanisms of proinflammatory cytokines, environmental lifestyles stress factors, and the influence of probiotics on the transport of the precursor amino acids\u00a0tyrosine and tryptophan in neuropsychiatric disorders and in the ageing process.<\/p>\n<p>2016, Prof. Venizelos was awarded with the\u00a0<i>&#8220;Delphic Prize for Outstanding Contributions to Psychiatry and Related Sciences<\/i>&#8220;, and from 2017 he serves as Ambassador of the World Congresses of Biological Psychiatry.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2.jpg\" alt=\"Nikolaos_Venizelos_Orebro_University_2\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Nikolaos_Venizelos_Orebro_University_2\" onerror=\"this.style.display='none'\"  sizes=\"auto, (max-width: 768px) 100vw, 100vw\" srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University_2-315x470.jpg 315w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Proinflammatory Cytokines and Oxidative Stress Can Cause Cognitive Dysfunction in Schizo- phrenia, Bipolar Disorders, and Related CNS Diseases\n\t<\/h3>\n<ul>\n<li>Evidence that the pro-inflammatory cytokines and oxidative stress affect the functionality of neurotransmitter precursor amino acid transporters (the uptake of tyrosine and tryptophan significantly inhibits up 47%)<\/li>\n<li>Changes in the dopaminergic and serotonergic brain systems can lead to deterioration of, among others, the cognition and behavior in patients with schizophrenia, bipolar disorders, and related CNS diseases<\/li>\n<\/ul>\n\t<a href=\"\" target=\"_blank\" role=\"button\" rel=\"noopener\">\n\t\t\t\t\tPresentation not available\n\t<\/a>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.oru.se\/english\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.oru.se\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/professor-nikolaos-venizelos-265a661a\/\" target=\"_blank\" rel=\"noopener\">Visit Profile<\/a><\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Prof. Nikolaos Venizelos Professor emeritus and Head of the Neuropsychiatric Research Laboratory &amp; Biobank, Nutrition-Gut-Brain Interactions Research Centre (NGBI), School of Medical Sciences at \u00d6rebro University Nikolaos Venizelos studied biomedicine at Uppsala University in Sweden and in 1981 after his Master thesis in clinical chemistry &amp; physiology at the Karolinska Institutet, he obtained a professional&#8230;<\/p>\n","protected":false},"author":1,"featured_media":32897,"parent":32856,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-32896","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nikolaos Venizelos &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Nikolaos Venizelos studied biomedicine at Uppsala University in Sweden and in 1981 after his Master thesis in clinical chemistry &amp; physiology at the Karolinska Institutet\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nikolaos Venizelos &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Nikolaos Venizelos studied biomedicine at Uppsala University in Sweden and in 1981 after his Master thesis in clinical chemistry &amp; physiology at the Karolinska Institutet\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-29T22:09:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/\",\"name\":\"Nikolaos Venizelos &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University.jpg\",\"datePublished\":\"2020-08-10T10:39:19+00:00\",\"dateModified\":\"2023-04-29T22:09:40+00:00\",\"description\":\"Nikolaos Venizelos studied biomedicine at Uppsala University in Sweden and in 1981 after his Master thesis in clinical chemistry & physiology at the Karolinska Institutet\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gut-Brain Axis 2018 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nikolaos Venizelos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nikolaos Venizelos &#8226; BioTech Pharma Summit","description":"Nikolaos Venizelos studied biomedicine at Uppsala University in Sweden and in 1981 after his Master thesis in clinical chemistry & physiology at the Karolinska Institutet","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/","og_locale":"en_US","og_type":"article","og_title":"Nikolaos Venizelos &#8226; BioTech Pharma Summit","og_description":"Nikolaos Venizelos studied biomedicine at Uppsala University in Sweden and in 1981 after his Master thesis in clinical chemistry & physiology at the Karolinska Institutet","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2023-04-29T22:09:40+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/","name":"Nikolaos Venizelos &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University.jpg","datePublished":"2020-08-10T10:39:19+00:00","dateModified":"2023-04-29T22:09:40+00:00","description":"Nikolaos Venizelos studied biomedicine at Uppsala University in Sweden and in 1981 after his Master thesis in clinical chemistry & physiology at the Karolinska Institutet","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Nikolaos_Venizelos_Orebro_University.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/nikolaos-venizelos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Gut-Brain Axis 2018 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/"},{"@type":"ListItem","position":3,"name":"Nikolaos Venizelos"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=32896"}],"version-history":[{"count":6,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32896\/revisions"}],"predecessor-version":[{"id":38249,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32896\/revisions\/38249"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32856"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/32897"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=32896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}